1131381

Janssen Pharmaceuticals, Inc — FEI 2242843

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 14, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Titusville, NJ (United States)